:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
These results support proactively reinforcing this advice in patients with type 2 diabetes receiving GLP-1RAs during this window
Data and code availability All data sourced from the FinnGen consortium (R9) ( Psychiatric Genomics Consortium (PGC, and UK Biobank ( All codes are available from the corresponding author through reasonable request
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in December 2024 were similar relative to September 2024 (+1.89%)
Demand Drivers: Efficacy and Bioavailability: Parenteral administration offers higher bioavailability, which is critical for the effectiveness of GLP-1 receptor agonists, particularly for the treatment of diabetes and obesity
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
